Doctors login

Press & Downloads

Contact details

Uschi Mayer
External Communications
Mobile: +43 676 84 68 68 966
E-mail: uschi.mayer@croma.at

press releases

2022

  • Croma-Pharma is expanding its management team
  • Croma-Pharma completed the decentralized procedure for its botulinum toxin to treat glabellar (frown) lines

2021

  • Croma-Pharma Announces 9-Country Licensing Agreement with Crescita Therapeutics for Pliaglis®
  • Croma-Pharma presents new cosmetic skincare brand "Croma farewell™" for common skin conditions

2020

  • Croma establishes new Joint Venture in China
  • Croma-Pharma GmbH expands its portfolio introducing pure HA
  • Croma-Pharma announces submission for their botulinum toxin to treat glabellar (frown) lines to the German authority BfArM
  • BVI forges strategic partnership with Croma-Pharma
  • Croma-Pharma supports Light for the World

2019

  • Croma-Pharma GmbH establishes affiliate in UK
  • Croma-Pharma reveals new packaging design for the Arthrex ACP® double syringe system
  • Croma-Pharma GmbH expands its portfolio introducing elure

2018

  • Croma-Pharma: "Made in Austria" - with minimally invasive aesthetic medicine (MIAM) becoming a global player

    Leobendorf, March 2018 - Croma-Pharma GmbH, or Croma for short, is an international pharmaceutical company based in Leobendorf, Austria. For over 40 years, innovative drugs and medical devices for the fields of ophthalmology, orthopedics and aesthetic dermatology have been developed and produced. Thus, Croma has made important contributions to improving health and quality of life for four decades.